Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M145Revenue (TTM) $M57.8Net Margin (%)-78.6Altman Z-Score-3.2
Enterprise Value $M98.9EPS (TTM) $-0.4Operating Margin %-22.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.5Pre-tax Margin (%)-78.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %-7.1Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-16.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VVUSFirst Eagle Investment 2013-06-30 Sold Out -0.0073%$10.43 - $15.1
($12.94)
$ 1.38-89%Sold Out0
VVUSFirst Eagle Investment 2013-03-31 Buy 0.01%$10.2 - $14.87
($12.43)
$ 1.38-89%New holding200,000
VVUSGeorge Soros 2012-09-30 Sold Out -0.06%$17.81 - $29.93
($23.45)
$ 1.38-94%Sold Out0
VVUSGeorge Soros 2012-06-30 Reduce-0.09%$21.5 - $28.68
($24.02)
$ 1.38-94%Reduce -64.93%150,000
VVUSGeorge Soros 2012-03-31 Buy 0.14%$9.99 - $23.78
($14.83)
$ 1.38-91%New holding427,750
VVUSGeorge Soros 2011-03-31 Sold Out $6.06 - $11.2
($7.95)
$ 1.38-83%Sold Out0
VVUSGeorge Soros 2010-12-31 Buy $5.94 - $9.78
($7.38)
$ 1.38-81%New holding19,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VVUS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Varghese Santosh TChief Medical Officer, 10% Owner 2016-10-01Sell710$1.1421.05view
Varghese Santosh TChief Medical Officer 2016-08-02Sell12,559$1.0728.97view
Varghese Santosh TVP, Medical & Reg Affairs 2016-07-01Sell366$1.2114.05view
Varghese Santosh TChief Medical Officer 2016-04-07Sell329$1.65-16.36view
NORTH TIDE CAPITAL, LLC10% Owner 2016-04-01Buy2,160$1.4-1.43view
NORTH TIDE CAPITAL, LLC10% Owner 2016-03-31Buy383,300$1.296.98view
NORTH TIDE CAPITAL, LLC10% Owner 2016-03-28Buy202,000$1.1223.21view
NORTH TIDE CAPITAL, LLC10% Owner 2016-03-16Buy500,000$1.2114.05view
Varghese Santosh TChief Medical Officer 2016-01-13Sell1,553$0.9545.26view
Varghese Santosh TVP, Medical & Reg Affairs 2015-07-01Sell7,899$2.32-40.52view

Press Releases about VVUS :

Quarterly/Annual Reports about VVUS:

News about VVUS:

Articles On GuruFocus.com
Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) Apr 01 2015 
5-year lows: PICO Holdings Inc, Black Box Corp, Vivus, and Electro Rent Corp. Mar 29 2015 
A Look at Pharma Company Dermira's Performance Mar 27 2015 
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
Unique Investor Kyle Bass Unloads Five May 29 2013 
Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

More From Other Websites
Increased Earnings Estimates Seen for VIVUS (VVUS): Can It Move Higher? Dec 05 2016
VIVUS (VVUS) Shows Strength: Stock Adds 5.1% in Session Nov 21 2016
ETFs with exposure to VIVUS, Inc. : November 18, 2016 Nov 18 2016
VIVUS INC Financials Nov 17 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Submission of Matters... Nov 14 2016
VIVUS, Inc. :VVUS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Nov 14 2016
VIVUS (VVUS) Reports Narrower-than-Expected Loss in Q3 Nov 11 2016
Edited Transcript of VVUS earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016
Vivus reports 3Q loss Nov 09 2016
Vivus reports 3Q loss Nov 09 2016
VIVUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to... Nov 09 2016
VIVUS Reports 2016 Third Quarter Financial Results Nov 09 2016
VIVUS Reports 2016 Third Quarter Financial Results Nov 09 2016
Q3 2016 VIVUS Inc Earnings Release - After Market Close Nov 09 2016
VIVUS Announces Date of 2016 Third Quarter Business Update and Financial Results Teleconference Oct 26 2016
VIVUS Announces Date of 2016 Third Quarter Business Update and Financial Results Teleconference Oct 26 2016
Mylan Up on EpiPen Medicaid Settlement, Cuts 2016 Outlook Oct 12 2016
Earnings Estimates Moving Higher for VIVUS (VVUS): Time to Buy? Oct 06 2016
The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and... Oct 05 2016
VIVUS Licenses Stendra Rights to Metuchen Pharmaceuticals Oct 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)